Literature DB >> 2887786

The syndrome of disappearing intrahepatic bile ducts.

S Sherlock.   

Abstract

Diseases with disappearing intrahepatic bile ducts may be developmental, immunological, infective, vascular, or chemical in origin. The immunological group includes primary biliary cirrhosis, graft-versus-host disease, and sarcoidosis. HLA class 2 antigens are displayed on the bileducts and recognition of biliary antigens by cytotoxic T-cells leads to destruction of interlobular ducts. Primary sclerosing cholangitis is associated with immunological features, but the hepatic histology is not that of immunological duct disease. The association with immunodeficiency syndromes, and the finding that secondary sclerosing cholangitis may occur in patients with the acquired immunodeficiency syndrome who are infected with cytomegalovirus, suggest that primary sclerosing cholangitis might be infective in origin. In bacterial cholangitis there is contiguity between the biliary system and the intestinal tract and usually, but not necessarily, partial biliary obstruction. Interference with the hepatic arterial supply to the bileducts leads to vascular cholangitis. Chemical cholangitis follows injection of scolicidal agents into the biliary tree. Diseases with disappearing bileducts have a long natural history and hepatocellular failure occurs late. In the late stages hepatic transplantation gives good results.

Entities:  

Mesh:

Year:  1987        PMID: 2887786     DOI: 10.1016/s0140-6736(87)91802-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid.

Authors:  J P Richardet; A Mallat; E S Zafrani; M Blazquez; J C Bognel; B Campillo
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

2.  Diagnostic approach to patients with cholestatic jaundice.

Authors:  N Assy; G Jacob; G Spira; Y Edoute
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

3.  Sonographic diagnosis of cholangitis in AIDS patients.

Authors:  D Defalque; Y Menu; P M Girard; J P Coulaud
Journal:  Gastrointest Radiol       Date:  1989

4.  Peribiliary vascular diseases in rejected livers; computer-aided three-dimensional reconstruction and morphometry.

Authors:  M Takemura; S Oguma; S Mori; M Ishii; T E Starzl; A J Demetris; T Takahasi
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

5.  Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature.

Authors:  A K Singal; C M Stanca; V Clark; L Dixon; C Levy; J A Odin; M I Fiel; S L Friedman; N Bach
Journal:  Hepatol Int       Date:  2011-03-11       Impact factor: 6.047

Review 6.  Liver disease in women. Alcohol, autoimmunity, and gallstones.

Authors:  S Sherlock
Journal:  West J Med       Date:  1988-12

7.  HLA-A33/B44/DR6 is highly related to intrahepatic cholestasis induced by tiopronin.

Authors:  M Kurosaki; H Takagi; M Mori
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 8.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

9.  Ductopenia related liver sarcoidosis.

Authors:  Nourr-Eddine Farouj; Jean-François D Cadranel; Ali Mofredj; Vincent Jouannaud; Maria Lahmiri; Pierre Le Lann; Alain Cazier
Journal:  World J Hepatol       Date:  2011-06-27

10.  The development of a pyogenic liver abscess following radical resection of cholangiocellular carcinoma with ligation of the right hepatic artery: report of a case.

Authors:  K Tanaka; A Nishimura; K Hombo; A Furoi; A Ikoma; T Yamauchi; A Taira
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.